US EditionPublished • loading... • Updated
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025
- Innovent Biologics will present research findings at the 34th European Academy of Dermatology and Venereology Congress in Paris from September 17-20.
- The showcased studies include clinical results of IBI112, along with preclinical results for IBI3013 and IAR129, which will be presented via ePoster.
- Huizhong Xiong stated that the company aims to address unmet needs in autoimmune skin diseases.
- Innovent expects to receive marketing approval for picankibart by the end of this year.
Insights by Ground AI
24 Articles
24 Articles
Fox 4 Kansas City+22 Reposted by 22 other sources
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025
·Kansas City, United States
Read Full ArticleCoverage Details
Total News Sources24
Leaning Left2Leaning Right1Center10Last UpdatedBias Distribution77% Center
Bias Distribution
- 77% of the sources are Center
77% Center
15%
C 77%
Factuality
To view factuality data please Upgrade to Premium
